PatientsVille.com Logo


Vitron-c Medical Research Studies

Up-to-date List of Vitron-c Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Vitron-c Medical Research Studies

Rank Status Study
1 Unknown  Vulvar Contact Dermatitis Resulting From Urine Incontinence
Conditions: Urinary Incontinence;   Vulvar Pruritus;   Vulvar Contact Dermatitis
Intervention: Other: Questionnaires, gynecological exam , vaginal smear, and measurement of urine leakage
Outcome Measures: Prevalence of vulvar contact dermatitis among patients with Urinary Incontinence;   Risk factors for Urinary Incontinence induced vulvar contact dermatitis
2 Recruiting Defeating Urinary Incontinence With Exercise Training (DUET) Feasibility Study
Conditions: Toileting Disability;   Functional Urinary Incontinence
Intervention: Behavioral: Behavioral Urinary Incontinence Treatment
Outcome Measures: Performance Oriented Timed Toileting Instrument (POTTI);   Toileting Skills Questionnaire;   International Consultation on Incontinence Questionnaire (ICIQ);   3 day bladder diary;   Short Physical Performance Battery;   Environmental toileting barriers checklist;   Incontinence Impact Questionnaire (IIQ);   Urogenital Distress Inventory (UDI)
3 Recruiting Study of Macroplastique Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence
Condition: Stress Urinary Incontinence
Intervention: Device: Macroplastique
Outcome Measures: To describe the incidence of additional or alternative treatment for stress Urinary Incontinence due to ISD following up to two Macroplastique treatments over a 5 year period.;   To describe the incidence of genitourinary and treatment related adverse events, including transient symptoms associated with the injection procedure.
4 Unknown  A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence
Conditions: Stress Urinary Incontinence;   Urgency Urinary Incontinence
Intervention: Drug: solifenacin
Outcome Measures: Changes in the number of urge Urinary Incontinence episodes per 24 hours between baseline and week 12;   Percent change in the mean number of urge Urinary Incontinence episodes per 24 hours;   Change in the mean number of urge Urinary Incontinence episodes per 24 hours;   Change in the mean frequency of urination per 24 hours;   Percent change in the mean frequency of urination;   Changes in the mean and sum rating on the Bladder Sensation Scale per 24 hours;   Change in the mean number of severe urgency episodes per 24 hours;   Changes in overactive bladder symptom score (OABSS) questionnaire;   Changes in short urogenital distress inventory (UDI-6);   Changes in short incontinence impact questionnaire (IIQ-7);   Safety assessed by the incidence and severity of side effects
5 Recruiting Proteomic Pattern in Female Stress Urinary Incontinence: a Pilot Study
Condition: Female Stress Urinary Incontinence
Intervention: Other: collection of urine and blood sample
Outcome Measure: mass spectrometric measuring of urinary proteomic secretome in diseased and healthy subjects (sequence coverage and number of identified proteins)
6 Recruiting Retropubic Single Incision Minisling Versus Tension Free Vaginal Tape for Management of Stress Urinary Incontinence
Condition: Stress Urinary Incontinence
Interventions: Procedure: single incision minisling;   Procedure: tension free vaginal tape
Outcome Measures: objective cure rate of Urinary Incontinence at 12 months after surgery;   subjective cure rate of Urinary Incontinence at 12 months after surgery;   Number of participants with short- term complications;   Number of participants with long-term complications
7 Not yet recruiting Stress Urinary Incontinence Physiotherapy
Condition: Urinary Incontinence, Stress
Interventions: Other: Involuntary muscle contractions;   Other: Voluntary muscle contractions
Outcome Measures: International Consultation on Incontinence Modular Questionnaire - Urinary Incontinence short form (ICIQ-UIsf (short form));   Pelvic floor muscle electromyography;   20-minute PAD-test;   International Consultation on Incontinence Modular Questionnaire - Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
8 Not yet recruiting Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS)
Conditions: Urinary Incontinence;;   Multiple Sclerosis
Intervention: Behavioral: Paula method
Outcome Measures: Urinary Incontinence ,measured by The ICIQ-SF Short Form questionnaire;   quality of life, sexual function and mobility
9 Recruiting Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO)
Condition: Urinary Incontinence
Intervention: Drug: Adipose-derived expanded stem cells
Outcome Measures: Evaluate the feasability and security of the autologous ASC for the feminine stress Urinary Incontinence;   Quality of life assessment using the SF-12 Questionnaire;   Adverse events
10 Not yet recruiting Transobturator Subtrigonal Tape vs Transobturator Suburethral Tape for Stress Urinary Incontinence
Condition: Stress Urinary Incontinence
Interventions: Procedure: transobturator subtrigonal tape S-TOT;   Procedure: Transobturator suburethral tape (TOT)
Outcome Measures: Stress Urinary Incontinence resolution, without postoperative obstruction;   Complications
11 Not yet recruiting Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence
Conditions: Stroke;   Urinary Incontinence
Intervention: Device: NeuroTrac continence stimulators
Outcome Measures: Frequency of reported episodes of Urinary Incontinence as a measure of effectiveness.;   Changes in the severity of Urinary Incontinence episodes experienced.;   Number of participants with adverse events as a measure of safety and tolerability.;   Changes in severity of urinary urgency, frequency and nocturia.;   Urinary symptoms experienced on the American Urological Association Symptom Index;   Mean Urgency Perception Scores recorded on a 3 day bladder diary;   Patient Perception of Bladder Condition;   Severity of bowel symptoms;   Patient Perception of Bowel Condition;   Changes in Barthel Index Score;   Changes in Modified Rankin Score;   Changes in post-void residual urine volume.;   Amount of urine leakage in 24 hours
12 Recruiting An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A
Outcome Measures: Percentage of Patients Who have Greatly Improved or Improved on the 4-Point Treatment Benefit Scale (TBS);   Change From Baseline in Number of Urinary Incontinence Episodes;   Time to Re-Injection of BOTOX®;   Number of Nocturia Episodes;   Usage of Incontinence Support Products;   Percentage of Patients Who Have at Least a 50% Reduction in Urinary Incontinence and Urinary Urgency Incontinence
13 Recruiting The Efficacy of Electroacupuncture for Treatment of Simple Female Stress Urinary Incontinence: Comparison With Pelvic Floor Muscle Training-a Multicenter Randomized Controlled Trial
Condition: Simple Stress Urinary Incontinence
Interventions: Device: electroacupuncture group;   Behavioral: pelvic floor muscle training group
Outcome Measures: Difference of frequency of leakage in mean 24h based on 72h diary, compared with the baseline;   Difference of amount of leakage in mean 24h based on 72h diary, compared with the baseline;   Difference of 1h pad test, compared with the baseline;   ICIQ-SF;   Patient subjective effectiveness evaluation;   Weekly usage of pad;   Usage of specialty therapy for Simple female stress Urinary Incontinence;   Subgroup analysis: amount of leakage with 1h pad test as a measure of curative effect of electroacupuncture for different extent of simple female stress Urinary Incontinence.
14 Recruiting The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence
Condition: Stress Urinary Incontinence
Intervention: Device: Altis Single Incision Sling System
Outcome Measures: Proportion of subjects who meet the criteria of cure at 12 months;   Proportion of subjects who have a negative cough stress test at each visit;   Proportion of subjects who meet the criteria of cure at each other visit;   Subject continence status measured by the 24-hour pad weight;   Assessment of self reported symptoms and subject QoL through the scoring of validated questionnaires: ICIQ-UI SF, I-QOL, UDI-6 and IIQ-7;   Postoperatively subject impression of improvement (via PGI-I questionnaire) and satisfaction at each post-operative visit;   Assessment of Qmax variations;   Assessment of PVR variations;   Assessment of the operation duration and the type of anaesthesia used;   Assessment of device and procedure related adverse events;   Assessment of postoperative pain
15 Recruiting Safety and Efficacy Study of Regen Sling to Treatment SUI
Condition: Stress Urinary Incontinence
Interventions: Device: Regen sling;   Device: tension-free vaginal tape-obturator(TVT-O)
Outcome Measures: pressure test (subjective indicator);   one-hour pad test(objective indicator);   Urinary Incontinence Impact Questionnaire - Table 7.(IIQ-7);   Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire - Table 12. (PISQ-12)
16 Recruiting Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
Condition: Urinary Incontinence, Urge
Interventions: Drug: Anticholinergic medications;   Behavioral: Hypnotherapy
Outcome Measures: Urgency Urinary Incontinence episodes recorded on voiding diaries;   Evoked brain activation and resting connectivity on functional MRI;   Urinary urge incontinence cure;   Questionnaire scores;   urinary frequency and pad counts;   Irritable bowel syndrome and bowel symptoms and/or Painful Bladder/Interstitial Cystitis in this population
17 Recruiting Virtue® European Study
Condition: Stress Urinary Incontinence
Intervention: Device: Virtue® Male Sling
Outcome Measures: Improvement of Urinary Incontinence based on 24-hour pad test;   Safety of the device characterized by reported adverse events;   Improvement of Urinary Incontinence based on number of pad used;   Subject reported improvement measured by the PGI-I;   Assessment of the frequency, severity and impact on quality of life of Urinary Incontinence based on ICIQ-UI short form;   Patient satisfaction questionaire
18 Recruiting Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence
Condition: Stress Urinary Incontinence
Interventions: Device: Active Neurotech Vital;   Device: Modified Neurotech Vital Device
Outcome Measures: All participants taking part in a standardised 1-minute stress test;   All participants to complete a Quality of life questionnaire (I-QOL);   participants taking part in a 1 minute stress test;   participants taking part in a 1-hour pad weight test;   particpants taking part in the stress test and then having the pad weight to show loss of urine.;   1-hour pad weight test;   quality of life questionnaire;   24 hour pad weight test;   24hour pad weight test;   3-day diary card;   3-day voiding diary;   Modified Oxford Score;   Pelvic floor ultrasound
19 Recruiting Solace Stress Urinary Incontinence Control Efficacy and Safety Study
Condition: Stress Urinary Incontinence
Interventions: Device: Solace Bladder Control Balloon;   Device: Solace Sham Treatment
Outcome Measures: Improvement in quality of life as assessed by pad weight tests assessments and questionnaires;   Incidence of treatment-related adverse events;   Severity of treatment-related adverse events
20 Recruiting Vitamin D Supplementation in Older Adults With Urinary Incontinence
Conditions: Urinary Incontinence;   Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D;   Other: Placebo
Outcome Measures: Change in the number of incontinent episodes on a 7-day bladder diary;   Change in UI symptoms (ICIQ-UI and ICIQ-OAB scores);   Change in quality of life (Overactive Bladder Questionnaire);   Change in satisfaction with treatment (Perceptions and Satisfaction Questionnaire);   Change in safety of the treatments (side effects and unanticipated events);   Mechanisms of improvement based on measure of mobility;   Bowel incontinence symptoms

These studies may lead to new treatments and are adding insight into Vitron-c etiology and treatment.

A major focus of Vitron-c research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Vitron-c